| Name | Description | Data sources | Responsible organisation(s) | Measure methodology last updated |
|---|---|---|---|---|
| People with diabetes regularly receiving empagliflozin | This indicator shows the number and percent of people with diabetes receiving empagliflozin regularly. Regular use was defined as empagliflozin dispensed in three or more quarters in a year. |
Pharmaceutical Collection (PHARMS), Virtual Diabetes Register | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| People with diabetes regularly receiving vildagliptin | This indicator shows the number and percent of people with diabetes receiving vildagliptin regularly. Regular use was defined as vildagliptin dispensed in three or more quarters in a year. |
Pharmaceutical Collection (PHARMS), Virtual Diabetes Register | Health Quality & Safety Commission | Te Tāhū Hauora | Last updated June 2024. This measure has not yet been updated. Refer to the Atlas of Healthcare Variation. |
| People with diabetes regularly receiving metformin in the relevant year | This indicator shows the number and percent of people with diabetes receiving metformin regularly. Regular use was defined as metformin dispensed in three or more quarters in a year. |
Pharmaceutical Collection (PHARMS), Virtual Diabetes Register | Health Quality & Safety Commission | Te Tāhū Hauora | Last updated June 2024. This measure has not yet been updated. Refer to the Atlas of Healthcare Variation. |
| Prevalence of diabetes | This indicator shows the number and percent of the PHO-enrolled New Zealand population recorded as having diabetes in the VDR. |
Health New Zealand | Te Whatu Ora | Last updated June 2024. This measure has not yet been updated. Refer to the Atlas of Healthcare Variation. |